The partnership with AT&T provides significant exposure to over 100 million eligible customers, representing substantial growth potential for LifeMD's virtual care and pharmacy services platform.
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock news
About LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock
Also mentions LFMDP
Articles that tag LFMDP but are mainly about other companies.
LifeMD secured an exclusive telehealth partnership with a major pharmaceutical company, expanding its service offerings and market reach. The collaboration leverages LifeMD's existing infrastructure (medical group, pharmacy, patient care center) to enter a new therapeutic area, potentially creating a new revenue stream and positioning the company as a leader in virtual specialty care delivery.
Selected as initial telehealth partner for Wegovy subscription distribution, expanding its obesity treatment offerings and revenue opportunities.
The dividend declaration is a routine corporate action that demonstrates the company's ability to maintain preferred dividend payments. However, the announcement itself contains no information about business performance, growth, or operational changes that would warrant a positive or negative sentiment. It is a standard financial obligation being met.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology